EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Catheter Precision's Enterprise Value is $3.58 Mil.
Catheter Precision's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-8.38 Mil. Therefore, Catheter Precision's EV-to-FCF for today is -0.43.
The historical rank and industry rank for Catheter Precision's EV-to-FCF or its related term are showing as below:
VTAK'
s EV-to-FCF Range Over the Past 10 Years
Min: -23.48 Med: 0.15 Max: 1.1
Current: -0.43
During the past 8 years, the highest EV-to-FCF of Catheter Precision was 1.10. The lowest was -23.48. And the median was 0.15.
VTAK's EV-to-FCF is ranked worse than 100% of 374
companies
in the Medical Devices & Instruments industry
Industry Median: 28.735
vs VTAK: -0.43
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for Catheter Precision's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Catheter Precision's EV-to-FCF
For the Medical Devices subindustry, Catheter Precision's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Catheter Precision's EV-to-FCF falls into.
Catheter Precision's current Enterprise Value is $3.58 Mil.
Catheter Precision's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Catheter Precision's PE Ratio (TTM) for today is calculated as:
Catheter Precision's share price for today is $0.354.
Catheter Precision's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Catheter Precision EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Catheter Precision's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VTAK has been successfully added to your 